Tandem Diabetes Care, Inc. recalls t:slim X2 insulin pump with Interoperable Technology
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- A software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an unexpected automatic insulin correction bolus (autobolus ) which could result in hypoglycemia.
- Products
-
- t:slim X2 insulin pump with Interoperable Technology
- Company
- Tandem Diabetes Care, Inc.
- Where it was sold
-
US nationwide distribution including Puerto Rico.
Nationwide
- Barcodes
0038915240701200389152480114- Units affected
- 122,958
- About this recall
- t:slim X2 insulin pump with Interoperable Technology, Control-IQ+ technology, REF: 1014070, 1014071, 1014072, 1014073, and User Guide when using Dexcom G7 sensor; Tandem Mobi insulin pump with Interoperable Technology, Control-IQ+ technology, REF: 1014801, 1014811, 1014813, and User Guide when using Dexcom G7 sensor